Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
| Status: | Archived |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | February 2012 |
| End Date: | April 2012 |
| Contact: | Nicola Pannacciulli, MD, PhD |
| Email: | Nico.Pannacciulli@gilead.com |
| Phone: | (650) 522-5833 |
A Phase 1, Open-Label, Single Cohort, Four-period Sequential Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine in Subjects With Type 2 Diabetes Mellitus
The purpose of this study is to evaluate the effect of steady-state ranolazine on the steady
state PK of metformin in subjects with type 2 diabetes mellitus (T2DM).
The primary objective of this study is as follows:
• To evaluate the effect of steady-state ranolazine on the steady state PK of metformin in
subjects with T2DM.
The secondary objectives of this study are as follows:
- To examine the safety and tolerability of metformin when co administered with
ranolazine at steady-state in subjects with T2DM.
- To determine the steady-state PK of ranolazine in subjects with T2DM receiving
metformin.
We found this trial at
1
site
Click here to add this to my saved trials
